162 related articles for article (PubMed ID: 10695689)
1. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group.
Wassertheil-Smoller S; Fann C; Allman RM; Black HR; Camel GH; Davis B; Masaki K; Pressel S; Prineas RJ; Stamler J; Vogt TM
Arch Intern Med; 2000 Feb; 160(4):494-500. PubMed ID: 10695689
[TBL] [Abstract][Full Text] [Related]
2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
3. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
[TBL] [Abstract][Full Text] [Related]
4. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).
Wassertheil-Smoller S; Applegate WB; Berge K; Chang CJ; Davis BR; Grimm R; Kostis J; Pressel S; Schron E
Arch Intern Med; 1996 Mar; 156(5):553-61. PubMed ID: 8604962
[TBL] [Abstract][Full Text] [Related]
5. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
[TBL] [Abstract][Full Text] [Related]
7. Association between chlorthalidone treatment of systolic hypertension and long-term survival.
Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR
JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278
[TBL] [Abstract][Full Text] [Related]
8. Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program.
Somes GW; Kritchevsky SB; Shorr RI; Pahor M; Applegate WB
Am J Epidemiol; 2002 Jul; 156(2):132-8. PubMed ID: 12117704
[TBL] [Abstract][Full Text] [Related]
9. Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program.
Kostis WJ; Sargsyan D; Mekkaoui C; Moreyra AE; Cabrera J; Cosgrove NM; Sedjro JE; Kostis JB; Cushman WC; Pantazopoulos JS; Pressel SL; Davis BR
J Hum Hypertens; 2019 Oct; 33(10):735-740. PubMed ID: 30804464
[TBL] [Abstract][Full Text] [Related]
10. The role of diastolic blood pressure when treating isolated systolic hypertension.
Somes GW; Pahor M; Shorr RI; Cushman WC; Applegate WB
Arch Intern Med; 1999 Sep; 159(17):2004-9. PubMed ID: 10510985
[TBL] [Abstract][Full Text] [Related]
11. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
[TBL] [Abstract][Full Text] [Related]
12. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
[TBL] [Abstract][Full Text] [Related]
13. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project.
Siegel D; Kuller L; Lazarus NB; Black D; Feigal D; Hughes G; Schoenberger JA; Hulley SB
Am J Epidemiol; 1987 Sep; 126(3):385-99. PubMed ID: 3303916
[TBL] [Abstract][Full Text] [Related]
14. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.
Gerdts E; de Simone G; Lund BP; Okin PM; Wachtell K; Boman K; Nieminen MS; Dahlöf B; Devereux RB
Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):122-9. PubMed ID: 21775111
[TBL] [Abstract][Full Text] [Related]
15. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
16. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.
Staessen J; Fagard R; Amery A
J Hum Hypertens; 1991 Dec; 5(6):469-74. PubMed ID: 1791605
[TBL] [Abstract][Full Text] [Related]
17. Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
Patel AB; Kostis JB; Wilson AC; Shea ML; Pressel SL; Davis BR
Stroke; 2008 Apr; 39(4):1084-9. PubMed ID: 18309155
[TBL] [Abstract][Full Text] [Related]
18. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.
Wilson PW; D'Agostino RB; Sullivan L; Parise H; Kannel WB
Arch Intern Med; 2002 Sep; 162(16):1867-72. PubMed ID: 12196085
[TBL] [Abstract][Full Text] [Related]
19. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Weber MA; Jamerson K; Bakris GL; Weir MR; Zappe D; Zhang Y; Dahlof B; Velazquez EJ; Pitt B
Lancet; 2013 Feb; 381(9866):537-45. PubMed ID: 23219284
[TBL] [Abstract][Full Text] [Related]
20. [A prospective study on body mass index and mortality].
Zhao L; Zhou B; Wu Y; Li Y; Yang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Feb; 23(1):24-7. PubMed ID: 12015104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
